Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
No association of tobacco use and disease activity in multiple sclerosis.
The Prevalence of Bipolar Disorders and Association With Quality of Life in a Cohort of Patients With Multiple Sclerosis.
Down-regulation of neuronal L1 cell adhesion molecule expression alleviates inflammatory neuronal injury.
Pediatric multiple sclerosis: Cognition and mood.
Reducing costs while enhancing quality of care in MS.
Lithium improves cell viability in psychosine-treated MO3.13 human oligodendrocyte cell line via autophagy activation.
Prevalence of multiple sclerosis in Health District III, Murcia, Spain.
Severe articular and musculoskeletal pain: An unexpected side effect of dimethyl-fumarate therapy for multiple sclerosis.
An emerging role for eotaxins in neurodegenerative disease.
Glucocorticoid receptor haplotypes conferring increased sensitivity (BclI and N363S) are associated with faster progression of multiple sclerosis.
Evaluation of transiently evoked otoacoustic emissions and auditory brainstem responses in patients with multiple sclerosis.
Iranian consensus on use of vitamin D in patients with multiple sclerosis.
Learning Objectives.
CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study.
Individualized Rituximab Treatment for Neuromyelitis Optica Spectrum Disorders.
HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation.
Muscular, cardiac, ventilatory and metabolic dysfunction in patients with multiple sclerosis: Implications for screening, clinical care and endurance and resistance exercise therapy, a scoping review.
Comparative Analysis for the Presence of IgG Anti-Aquaporin-1 in Patients with NMO-Spectrum Disorders.
Sympathetic cardiovascular and sudomotor functions are frequently affected in early multiple sclerosis.
Improvement of spasticity following intermittent theta burst stimulation in multiple sclerosis is associated with modulation of resting-state functional connectivity of the primary motor cortices.
Risk factors in multiple sclerosis: a population-based case-control study in Sicily. Background and methods.
Report: Stem cell applications in neurological practice, an expert group consensus appraisal.
Interleukin 2 activates brain microvascular endothelial cells resulting in destabilization of adherens junctions.
Predicting early signs of dyslexia at a preliterate age by combining behavioral assessment with structural MRI.
Is monocyte- and macrophage-derived tissue transglutaminase involved in inflammatory processes?
Pages
« first
‹ previous
…
798
799
800
801
802
803
804
805
806
…
next ›
last »